Rua Bioscience Statistics

Total Valuation

Rua Bioscience has a market cap or net worth of NZD 10.82 million. The enterprise value is 10.46 million.

Market Cap	10.82M
Enterprise Value	10.46M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Rua Bioscience has 338.04 million shares outstanding. The number of shares has increased by 62.31% in one year.

Current Share Class	338.04M
Shares Outstanding	338.04M
Shares Change (YoY)	+62.31%
Shares Change (QoQ)	+37.64%
Owned by Insiders (%)	26.96%
Owned by Institutions (%)	2.50%
Float	222.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.52
PB Ratio	1.85
P/TBV Ratio	2.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.04
EV / Sales	4.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.42

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.31.

Current Ratio	1.58
Quick Ratio	0.90
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.77
Interest Coverage	-11.89

Financial Efficiency

Return on equity (ROE) is -56.91% and return on invested capital (ROIC) is -29.38%.

Return on Equity (ROE)	-56.91%
Return on Assets (ROA)	-25.83%
Return on Invested Capital (ROIC)	-29.38%
Return on Capital Employed (ROCE)	-57.75%
Weighted Average Cost of Capital (WACC)	7.77%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.29
Inventory Turnover	2.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.08% in the last 52 weeks. The beta is 0.50, so Rua Bioscience's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+23.08%
50-Day Moving Average	0.03
200-Day Moving Average	0.04
Relative Strength Index (RSI)	34.91
Average Volume (20 Days)	96,920

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rua Bioscience had revenue of NZD 2.39 million and -3.45 million in losses. Loss per share was -0.01.

Revenue	2.39M
Gross Profit	1.00M
Operating Income	-3.39M
Pretax Income	-3.45M
Net Income	-3.45M
EBITDA	-3.05M
EBIT	-3.39M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 2.17 million in cash and 1.81 million in debt, giving a net cash position of 353,399 or 0.00 per share.

Cash & Cash Equivalents	2.17M
Total Debt	1.81M
Net Cash	353,399
Net Cash Per Share	0.00
Equity (Book Value)	5.84M
Book Value Per Share	0.02
Working Capital	1.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.36 million and capital expenditures -3,431, giving a free cash flow of -2.37 million.

Operating Cash Flow	-2.36M
Capital Expenditures	-3,431
Free Cash Flow	-2.37M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 41.88%, with operating and profit margins of -141.84% and -144.06%.

Gross Margin	41.88%
Operating Margin	-141.84%
Pretax Margin	-144.06%
Profit Margin	-144.06%
EBITDA Margin	-127.63%
EBIT Margin	-141.84%
FCF Margin	n/a

Dividends & Yields

Rua Bioscience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-62.31%
Shareholder Yield	-62.31%
Earnings Yield	-31.86%
FCF Yield	-21.89%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rua Bioscience has an Altman Z-Score of -6.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.02
Piotroski F-Score	3